Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 21, 2016 - Issue 1
Submit an article Journal homepage
543
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ahmad H. AliDivision of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USACorrespondence[email protected]
,
James H. TabibianWilmott-Barna Center for Endoscopic Innovation, Research and Training, Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
,
Elizabeth J. CareyDivision of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA
&
Keith D. LindorDivision of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA;College of Health Solutions, Arizona State University, Phoenix, AZ, USA
Pages 39-56 | Received 10 Nov 2015, Accepted 02 Feb 2016, Published online: 23 Feb 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Amir Kalani, James H. Tabibian & Keith D. Lindor. (2018) Emerging therapeutic targets for primary sclerosing cholangitis. Expert Opinion on Orphan Drugs 6:7, pages 393-401.
Read now

Articles from other publishers (13)

Nathalie Pena Polanco, Claudia Cottone & Kalyan Ram Bhamidimarri. (2020) PSC and Overlap Syndromes. Current Hepatology Reports 19:2, pages 106-118.
Crossref
Yunwen Yang, Suwen Liu, Huiping Gao, Peipei Wang, Yue Zhang, Aihua Zhang, Zhanjun Jia & Songming Huang. (2020) Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2. Free Radical Biology and Medicine 152, pages 821-837.
Crossref
Tingting Li, Lijie Xu, Rongyao Zheng, Xinjie Wang, Liwen Li, Hui Ji & Qinghua Hu. (2020) Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Phytomedicine 68, pages 153153.
Crossref
Zhiyong Zhang, Yiru Miao, Min Xu, Wenming Cheng, Chuanyan Yang, Xiangjian She, Qianqian Geng & Qunlin Zhang. (2020) TianJiu therapy for α-naphthyl isothiocyanate-induced intrahepatic cholestasis in rats treated with fresh Ranunculus sceleratus L.. Journal of Ethnopharmacology 248, pages 112310.
Crossref
Yu-Sheng Chen, Hsuan-Miao Liu & Tzung-Yan Lee. (2019) Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. Cells 8:3, pages 253.
Crossref
Dongke Yu, Shi-Ying Cai, Albert Mennone, Pamela Vig & James L. Boyer. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver International 38:6, pages 1128-1138.
Crossref
Romina Mancinelli, Francesca Olivero, Guido Carpino, Diletta Overi, Luigi Rosa, Maria Stefania Lepanto, Antimo Cutone, Antonio Franchitto, Gianfranco Alpini, Paolo Onori, Piera Valenti & Eugenio Gaudio. (2018) Role of lactoferrin and its receptors on biliary epithelium. BioMetals 31:3, pages 369-379.
Crossref
Oihane Erice, Patricia Munoz‐Garrido, Javier Vaquero, Maria J. Perugorria, Maite G. Fernandez‐Barrena, Elena Saez, Alvaro Santos‐Laso, Ander Arbelaiz, Raul Jimenez‐Agüero, Joaquin Fernandez‐Irigoyen, Enrique Santamaria, Verónica Torrano, Arkaitz Carracedo, Meenakshisundaram Ananthanarayanan, Marco Marzioni, Jesus Prieto, Ulrich Beuers, Ronald P. Oude Elferink, Nicholas F. LaRusso, Luis Bujanda, Jose J.G. Marin & Jesus M. Banales. (2018) MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation. Hepatology 67:4, pages 1420-1440.
Crossref
Kais Zakharia, Anilga Tabibian, Keith D. Lindor & James H. Tabibian. (2018) Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver International 38:3, pages 399-411.
Crossref
Jia-Sheng Wu, Yi-Fei Li, Yuan-Yuan Li, Yan Dai, Wen-Kai Li, Min Zheng, Zheng-Chun Shi, Rong Shi, Tian-Ming Wang, Bing-Liang Ma, Ping Liu & Yue-Ming Ma. (2017) Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice. Frontiers in Pharmacology 8.
Crossref
David Chascsa, Elizabeth J. Carey & Keith D. Lindor. (2017) Old and new treatments for primary biliary cholangitis. Liver International 37:4, pages 490-499.
Crossref
Hani S. Mousa, Marco Carbone, Federica Malinverno, Vincenzo Ronca, M. Eric Gershwin & Pietro Invernizzi. (2016) Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach. Autoimmunity Reviews 15:9, pages 870-876.
Crossref
Sum P. Lee, Joseph R. Roberts & Rahul Kuver. (2016) The changing faces of cholangitis. F1000Research 5, pages 1409.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.